Pharmaceutical Serialization in the GCC: Spotlight on United Arab Emirates (UAE)
Welcome to the second entry in our blog series on pharmaceutical serialization across the Middle East. In this instalment, we focus on the United Arab...
Pharmaceutical Serialization in the GCC: Spotlight on Saudi Arabia
Welcome to the first entry in our blog series on pharmaceutical serialization across the Gulf Cooperation Council (GCC). In this series, we’ll explore...
Pharmaceutical Serialization in Emerging Markets: A New Era of Global Compliance
As pharmaceutical supply chains grow increasingly complex and global, the need for serialization has never been more urgent. While developed regions like...
China’s Push for Safer, Smarter Medicines: The Role of Drug Traceability Codes
On March 19, 2025, China’s National Healthcare Security Administration (NHSA) dropped an important announcement that’s shaking up how medications are...
Strengthening Global Health Supply Chains: USAID’s Approach to Enabling Traceability in Africa
Ensuring the authenticity and safety of medical products is a critical priority in global health supply chains. The U.S. Agency for International...
Navigating Misalignment Exception Management Under DSCSA: Challenges and Solutions
The U.S. Drug Supply Chain Security Act (DSCSA) aims to enhance pharmaceutical traceability, but misalignment exceptions remain a persistent challenge....
Italy's Transition from Bollino to EU-FMD: Proposed Deadline Extension and Industry Implications
Reference: 19th Legislature - 10th Permanent Commission - Summary report no. 247 of 26/11/2024 (Accessed on February 6, 2025....
Italy’s Transition from Bollino to FMD: Challenges and Preparation Guide for Pharmaceutical Manufacturers
Italy is embarking on a significant shift in its pharmaceutical regulation by transitioning from the Bollino system to the European Union’s Falsified...